Sun Pharma’s Utreglutide shows weight loss, gluco-metabolic and lipid-lowering efficacy
GL0034 (Utreglutide) administered once weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GL0034
Sun Pharma announces pre-clinical data on GL0034, an experimental NCE to treat Type 2 diabetes and…
The experimental New Chemical Entity (NCE), GL0034 is a long-acting GLP-1R (Glucagon-Like Peptide-1 Receptor) agonist